Insider Shareholders with Direct Ownership of Cerevel Therapeutics Holdings, Inc. (CERE)
This section provides a comprehensive overview of the insiders with direct ownership of Cerevel Therapeutics Holdings, Inc. (CERE). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Cerevel Therapeutics Holdings, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Ronald C Renaud Jr
President & CEO |
160,452 | 160,452 | 160,452 $0 | 2 |
Dec 19, 2023
Added 50.0%
|
28,013 | 42,283 | 42,283 $0 | 4 |
Jun 05, 2024
Added 19.83%
|
|
Orly Mishan
Chief Business Officer |
38,450 | 0 | 38,450 $0 | 1 |
Jan 26, 2021
Added 50.0%
|
13,743 | 13,743 | 13,743 $0 | 3 |
Jun 05, 2024
Added 43.22%
|
|
13,743 | 13,743 | 13,743 $0 | 3 |
Jun 05, 2024
Added 43.22%
|
|
950,730 | 953,434 | 0 $0 | 48 |
Aug 01, 2024
Reduced 100.0%
|
|
63,367 | 58,876 | 0 $0 | 6 |
Aug 01, 2024
Reduced 100.0%
|
|
1,200,000 | 27,349,211 | 0 $0 | 2 |
Aug 01, 2024
Reduced 100.0%
|
|
John Renger
Chief Scientific Officer |
481,125 | 484,636 | 0 $0 | 47 |
Aug 01, 2024
Reduced 100.0%
|
Scott Akamine
Chief Legal Officer |
41,296 | 42,099 | 0 $0 | 9 |
Aug 01, 2024
Reduced 100.0%
|
Abraham Ceesay
President |
96,056 | 96,056 | 0 $0 | 10 |
Sep 08, 2022
Reduced 100.0%
|
42,283 | 56,553 | 0 $0 | 5 |
Aug 01, 2024
Reduced 100.0%
|
|
91,578 | 91,578 | 0 $0 | 7 |
Aug 01, 2024
Reduced 100.0%
|
|
16,954 | 16,954 | 0 $0 | 4 |
Aug 01, 2024
Reduced 100.0%
|
|
13,743 | 13,743 | 0 $0 | 3 |
Aug 01, 2024
Reduced 100.0%
|
|
13,743 | 13,743 | 0 $0 | 3 |
Aug 01, 2024
Reduced 100.0%
|
|
24,017 | 27,508 | 0 $0 | 5 |
Aug 01, 2024
Reduced 100.0%
|
|
Pf Equity Holdings 1 B.V.
> 10% Shareholder |
0 | 27,349,211 | 0 $0 | 1 |
Mar 31, 2022
Reduced 100.0%
|
Ramiro Sanchez
Chief Medical Officer |
52,325 | 52,325 | 0 $0 | 9 |
Aug 01, 2024
Reduced 100.0%
|
Kenneth Di Pietro
Chief Human Resources Officer |
21,913 | 39,298 | 0 $0 | 5 |
Aug 01, 2024
Reduced 100.0%
|
Susan Altschuller
Chief Financial Officer |
30,721 | 30,721 | 0 $0 | 3 |
Aug 01, 2024
Reduced 100.0%
|
45,727 | 45,727 | 0 $0 | 3 |
Aug 01, 2024
Reduced 100.0%
|